Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion type Assertion NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_head.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion description "[Strong clinical and experimental evidence shows that elevated levels of urokinase plasminogen activators (u-PA) and matrix metalloproteinases (MMPs) are associated with prostate cancer progression, metastasis and shortened survival in patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_provenance.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion evidence source_evidence_literature NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_provenance.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion SIO_000772 21874261 NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_provenance.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion wasDerivedFrom befree-20140225 NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_provenance.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion wasGeneratedBy ECO_0000203 NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_provenance.